AU2761901A - Methods for inhibiting/treating hiv infections and aids related symptoms - Google Patents

Methods for inhibiting/treating hiv infections and aids related symptoms

Info

Publication number
AU2761901A
AU2761901A AU27619/01A AU2761901A AU2761901A AU 2761901 A AU2761901 A AU 2761901A AU 27619/01 A AU27619/01 A AU 27619/01A AU 2761901 A AU2761901 A AU 2761901A AU 2761901 A AU2761901 A AU 2761901A
Authority
AU
Australia
Prior art keywords
inhibiting
methods
related symptoms
treating hiv
hiv infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27619/01A
Other languages
English (en)
Inventor
Janos Aradi
Thomas J Bardos
Joseph A. Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therex Technologies Inc
Original Assignee
Therex Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therex Technologies Inc filed Critical Therex Technologies Inc
Publication of AU2761901A publication Critical patent/AU2761901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU27619/01A 2000-01-06 2001-01-05 Methods for inhibiting/treating hiv infections and aids related symptoms Abandoned AU2761901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17466800P 2000-01-06 2000-01-06
US60174668 2000-01-06
PCT/US2001/000280 WO2001049297A1 (fr) 2000-01-06 2001-01-05 Methodes d'inhibition/traitement d'infections par le vih et de symptomes lies au sida

Publications (1)

Publication Number Publication Date
AU2761901A true AU2761901A (en) 2001-07-16

Family

ID=22637045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27619/01A Abandoned AU2761901A (en) 2000-01-06 2001-01-05 Methods for inhibiting/treating hiv infections and aids related symptoms

Country Status (4)

Country Link
EP (1) EP1248631A4 (fr)
AU (1) AU2761901A (fr)
CA (1) CA2396240A1 (fr)
WO (1) WO2001049297A1 (fr)

Also Published As

Publication number Publication date
EP1248631A1 (fr) 2002-10-16
CA2396240A1 (fr) 2001-07-12
WO2001049297A8 (fr) 2002-02-07
EP1248631A4 (fr) 2003-05-28
WO2001049297A1 (fr) 2001-07-12

Similar Documents

Publication Publication Date Title
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002223827A1 (en) Well treatment
AU2001234088A1 (en) TNF-alpha inhibitors
EP1241577A3 (fr) Méthode et agencements pour le traitement amélioré de bandes de parités
AU2002215125A1 (en) Well treatment method
AU5250901A (en) Methods and devices for reducing trembling
AU2001239858A1 (en) Wastewater treatment process
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
AU2001232647A1 (en) Methods and devices for treating stuttering problems
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002323270A1 (en) Composition and method for treating hiv infection
AU2001286983A1 (en) Method of treatment
AU2002231206A1 (en) Treatment of depression
AU2001289831A1 (en) Medicaments against viral infections
AU2001232245A1 (en) Tnf- alpha inhibitors
AU2263801A (en) Quinolone compounds for use in treating viral infections
AU2002359327A1 (en) Method of treating viral infections
AU2002365168A1 (en) Method and composition for treating and preventing hiv infection and aids
AU2002242096A1 (en) Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms
AU2001258675A1 (en) Treating infections
AU2761901A (en) Methods for inhibiting/treating hiv infections and aids related symptoms
AU2001230253A1 (en) Processing method
AU2002221760A1 (en) Vaccine for treating allergy
AU2001233026A1 (en) Phosphodiesterases
AUPQ922100A0 (en) Waste treatment process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase